Illinois Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: IDHS/DBHR Licensure page (New License Application Instructions and Checklist) | Questions: DHS.DBHR.License@Illinois.gov, (312) 814-3840

In Illinois, the agency that licenses residential SUD treatment is the Illinois Department of Human Services, Division of Behavioral Health and Recovery (IDHS/DBHR), working under 77 Ill. Admin. Code Part 2060, a rule Illinois repealed and readopted in full effective April 2, 2025. DBHR is the product of Executive Order 2025-01, which the Governor signed on February 14, 2025 to combine SUPR (the Division of Substance Use Prevention and Recovery) with the Division of Mental Health, starting July 1, 2025 or as soon after that as practicable. The current Part 2060 text still refers to the licensing authority as “DHS/SUPR,” so expect to see both names on forms and in the rule.

No Accreditation Mandate or Certificate of Need for Most SUD Residential Programs

In our view, Illinois offers one of the more direct SUD residential licensing paths in the country. The licensing and application sections of Part 2060 don’t make national accreditation a condition of an ordinary treatment license, and Section 2060.220 says no application fee is required apart from narrow cases like a corporate dissolution or a relocation. The one exception to watch is methadone: under Section 2060.420(g), a program that also provides methadone has to meet federal opioid treatment program rules in 42 CFR Part 8 and keep its SAMHSA approval, DEA registration and accreditation documents on site for state review. Certificate of Need review comes from the Health Facilities Planning Act, and that Act’s list of covered facilities (hospitals, nursing homes, SMHRFs, surgery centers and others) doesn’t include SUD treatment programs licensed under Part 2060.

A license lasts up to three years under Section 2060.225(a), so a renewal can come sooner than that. DHS can inspect “at any reasonable time,” though Section 2060.392 says inspections are generally routinely scheduled and may include a pre-licensure visit. None of this makes the standards light. Section 2060.310 alone sets fire safety under the State Fire Marshal’s rules and the 2015 NFPA 101 Life Safety Code, written local zoning sign-off, minimum bedroom sizes of 80 square feet for a single room and 60 square feet per bed in shared rooms (four beds at most), a sink, toilet and tub or shower for every eight beds on any floor where bathrooms aren’t attached to bedrooms, and no bunk beds in withdrawal management.

Don’t Confuse SUD Residential With the SMHRF Cap

We see these two Illinois licensing tracks mixed up often, and the mix-up wastes real time. Specialized Mental Health Rehabilitation Facilities (SMHRFs) are licensed by the Illinois Department of Public Health under the Specialized Mental Health Rehabilitation Act of 2013, a law that reaches only long-term care facilities the federal government already classed as institutions for mental disease at the time it took effect. The Act caps beds, not facilities: total SMHRF licensed beds can never exceed the number that existed on July 22, 2013. As for how many SMHRFs exist, the narrative in IDPH’s 2025 long-term care report puts the 2024 figure at 20. None of that touches a Part 2060 residential SUD license issued by IDHS/DBHR, so if your program treats substance use disorders, the SMHRF bed cap isn’t your constraint.

Medication-Assisted Treatment in a Residential Setting

Dispensing methadone to treat opioid use disorder is the job of an opioid treatment program (OTP) holding federal certification under 42 CFR 8.11. Illinois regulates those programs inside Part 2060 itself: Section 2060.420(g) says DHS “authorizes, regulates, and inspects organizations that also provide Methadone,” and requires them to meet 42 CFR Part 8 and DEA rules. A residential program that won’t dispense methadone needs a working relationship with an OTP that does, and Section 2060.380 adds that referrals for SUD services may only go to organizations licensed under Part 2060 (or specifically exempted). From what we’ve seen, a policy that names the actual OTP partner and how transport and dosing are handled holds up far better in review than a line saying referrals happen as needed.

Buprenorphine is simpler. Since the Consolidated Appropriations Act, 2023 removed the federal waiver, DEA guidance says any practitioner licensed under state law to prescribe controlled substances can treat opioid use disorder with buprenorphine using a standard DEA registration. Section 2060.380 also requires that every client be offered an evaluation by a qualified prescriber regarding medication assisted recovery (MAR), and Part 2060’s residential withdrawal management levels expressly allow induction or a stable dose of MAR.

Ketamine Under a Part 2060 Residential License

Part 2060 never mentions ketamine. The points below are our reading of its medical services sections, the state controlled substance registration rules and Illinois corporate practice case law, so ask DBHR to confirm them for your program.

Medical care inside a Part 2060 program belongs to the medical director. Section 2060.420(a) says the medical director “shall oversee and authorize protocol for all medical services,” and subsection (f)(5) has medication “dispensed or administered as specified by the medical director.” A ketamine protocol for a resident with co-occurring depression or PTSD would therefore be one the medical director writes and signs, and Section 2060.415 says that at Level 3 the medical director is either a physician or a licensed advanced practice registered nurse. Ketamine isn’t a level of care, so in our view it isn’t the kind of “additional treatment or intervention service” Section 2060.225(b) has you request through the license application. We’d still describe the protocol to the DBHR Licensure Unit before the first dose rather than let an inspector find it.

Illinois licenses the address as well as the prescriber. IDFPR’s controlled substance instructions say “every person who prescribes, dispenses, or stores any controlled substances within the State” needs a state registration, and that “a separate registration is required for each place of business or professional practice” where drugs are stored or dispensed. DEA has the same per-location rule (21 CFR 1301.12(a)). Prescribers who hold an Illinois controlled substance license must also register with the Illinois Prescription Monitoring Program. Ketamine itself is Schedule III (21 CFR 1308.13(c)(7)) and FDA-labeled only for anesthesia, which makes depression treatment off-label and means it isn’t medication assisted recovery for opioid use disorder.

Two gaps are worth planning around. As far as we could find, IDFPR’s Board of Nursing has said nothing about RNs and sub-anesthetic ketamine, which leaves the medical director’s protocol to say who starts the line, who watches vitals and who can stop an infusion. Spravato (esketamine) brings its own conditions: a REMS-certified setting, self-administration in front of a clinician, and two hours or more of monitoring each session. Patient enrollment in the REMS is written for outpatients, and a residential bed doesn’t sit cleanly on either side of that line, so get the REMS program’s answer before scheduling.

Continuing After Discharge Under Illinois Ownership Rules

Illinois is one of the states where the follow-on clinic can’t simply be owned by the treatment company. In Berlin v. Sarah Bush Lincoln Health Center (1997), the Illinois Supreme Court said the corporate practice of medicine doctrine “prohibits corporations from providing professional medical services” and that this “is entirely appropriate to a general corporation,” while declining to apply it to licensed hospitals. A resident who responds to ketamine would continue at a physician-owned medical corporation or medical PLLC, with any operator-owned company limited to a management role, as laid out in the ketamine section of Illinois Drug and Alcohol Outpatient Treatment Licensing. Referral money between the two can draw scrutiny under two laws: the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220) and the Illinois Insurance Claims Fraud Prevention Act, which makes it unlawful to pay remuneration “to induce any person to procure clients or patients” for insured services and sets a civil penalty of $5,000 to $10,000 plus up to three times each claim (740 ILCS 92/5). The Illinois Act excludes certain contracts among insurers, health care professionals and facilities, so whether it reaches your arrangement is a question for counsel. Have counsel review the arrangement before the first referral.

Which Residential Levels Part 2060 Licenses

Section 2060.410 lists four residential levels a treatment license can cover: Level 3.1 (Clinically-Managed Low Intensity Residential), Level 3.2 (Clinically-Managed Residential Withdrawal Management), Level 3.5 (Clinically-Managed Medium to High Intensity Residential Services) and Level 3.7 (Medically-Monitored Inpatient Withdrawal Management). All four require staff awake and on duty 24 hours a day, seven days a week, and Level 3.1 adds at least five hours a week of clinical services from professional staff. The section doesn’t mention ASAM by name, and its only Level 3.7 is a withdrawal management level. As we read it, that leaves no Part 2060 license line for medically monitored residential treatment outside of withdrawal.

That gap is where CARF’s ASAM Level of Care Certification can matter. It is a separate credential from the Illinois license, offered for adult residential Levels 3.1, 3.5 and 3.7 and delivered in partnership with ASAM. CARF lists no withdrawal management level in that program, so it isn’t a substitute for the state’s 3.2 or 3.7 withdrawal management license. Our reading of Section 2060.410 is that a 3.7 certification has no matching residential line on a DBHR license. Anyone who wants to check it, a payer or a hospital discharge planner for example, can look the program up in CARF’s provider search and narrow the results by certification level. For 3.1 and 3.5 programs, certification is an outside check that lines up with levels the state already licenses by the same numbers.

Staffing a Residential Program

We found no state-issued addiction counselor license in Illinois, yet inside a licensed program the credential still isn’t optional. Section 2060.320(a) says professional staff delivering clinical treatment must hold, upon hire, a Certified Alcohol and Drug Counselor (CADC) credential from the Illinois Certification Board (ICB), or one of the listed licenses: LPC or LCPC, physician, clinical psychologist, LSW or LCSW, marriage and family therapist, or a board-certified psychiatric nurse practitioner or physician assistant with psychiatry certification. The ICB’s CADC application asks that you have worked in an alcohol and drug counseling position within the last four years. It also calls for 150 hours of face-to-face supervision and 100 hours of AOD-specific education among other coursework, and a qualifying degree can waive 1,000 (associate) or 2,000 (bachelor’s or higher) hours of work experience.

Round-the-clock coverage adds real cost. A residential program with a clinical director, several counselors, and 24-hour direct-care staff commonly runs well past $400,000 a year in payroll before nursing coverage is factored in. Part 2060 does leave one lever for that number. Under Section 2060.320(f), a new clinical hire without the credential can work under supervision for up to two years while earning it, but can’t hold a clinical supervisory role in the meantime and must stop providing clinical services if the two years run out. An operator can use that window for part of the counseling team, under credentialed supervisors, and in our experience it often makes sense to pair an RN with several LPNs for medical oversight rather than staffing every shift with a registered nurse. The specific staffing matrix comes together once census and level of care are confirmed.

How to Submit Your IDHS/DBHR Application

Start with the New License Application Instructions and Checklist on IDHS/DBHR’s licensure page, which also carries the Schedule E (Medical Director) form. Section 2060.215 calls the core form the “Substance Use Disorder Services Application for Intervention/Treatment License” and lists attachments such as IRS documents, Secretary of State filings, organizational charts, narrative descriptions, linkage agreements and the applicable schedules. Section 2060.200 also asks for an attestation that you’ve read the applicable rules and expects staff to be ready to deliver services on the date of licensure. If DHS flags corrections, Section 2060.240 gives you 60 calendar days to submit them before the application is returned. The licensure unit’s contact is DHS.DBHR.License@Illinois.gov or (312) 814-3840. Confirm the current submission method in the checklist itself before you send anything.

What Delays Illinois Residential Applications

In the applications we’ve worked on, two problems come up again and again. The first is a developer reading about the SMHRF bed cap and the Certificate of Need review that SMHRFs fall under, then spending weeks on restrictions that don’t reach a Part 2060 SUD residential license. The second is assuming the Section 2060.310 facility rules and the Section 2060.320 credential rules must be loose because accreditation isn’t a licensing condition, then finding out at the pre-licensure inspection that bedroom sizes or counselor credentials don’t measure up.

Frequently Asked Questions

Confirming whether the SMHRF cap applies to your Illinois SUD program? Reach out here.

Sources

• Illinois Administrative Code, 77 Ill. Adm. Code Part 2060 (new Part effective April 2, 2025): Part 2060 table of contents (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.410, Levels of Care, Treatment: Section 2060.410 (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.200, 2060.205, 2060.215, 2060.220, 2060.225, 2060.240 (application, fee, license term), via Cornell LII mirror of the official code: Part 2060 index (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.310, Facility Requirements: Section 2060.310 (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.320, Staff Qualifications: Section 2060.320 (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.380, Referral Procedure: Section 2060.380 (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.392, Compliance Inspections: Section 2060.392 (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.420(g), methadone providers: Section 2060.420 (checked October 7, 2026)
• IDHS-DBHR, licensure contacts and application checklists: IDHS-DBHR Licensure (checked October 7, 2026)
• IDHS, DMH and SUPR integration into the Division of Behavioral Health and Recovery: IDHS announcement (checked October 7, 2026)
• Office of the Governor, Executive Order 2025-01 (signed February 14, 2025): Creating the Division of Behavioral Health and Recovery (checked October 7, 2026)
• Specialized Mental Health Rehabilitation Act of 2013, 210 ILCS 49 (Sections 1-101.5, 4-105, 4-201): 210 ILCS 49 (checked October 7, 2026)
• Illinois Department of Public Health, Long-Term Care Annual Report 2025 (SMHRF count): IDPH LTC report (checked October 7, 2026)
• Health Facilities Planning Act, 20 ILCS 3960 (Sections 3 and 4): 20 ILCS 3960 (checked October 7, 2026)
• Illinois Certification Board, CADC application (April 2023): ICB AOD Counselor Application (checked October 7, 2026)
• 42 CFR 8.11, OTP certification: eCFR 42 CFR 8.11 (checked October 7, 2026)
• SAMHSA, waiver elimination (MAT Act): SAMHSA MAT Act page (checked October 7, 2026)
• DEA Diversion Control Division, buprenorphine FAQ: DEA buprenorphine FAQ (checked October 7, 2026)
• CARF International, ASAM Level of Care Certification: CARF LOC certification (checked October 7, 2026)
• ASAM, Level of Care Certification: ASAM LOC certification (checked October 7, 2026)
• CARF International, provider search: CARF Find a Provider (checked October 7, 2026)
• 77 Ill. Adm. Code 2060.415, 2060.420 and 2060.225, via Cornell LII: Medical director, Medical services and Period of licensure (checked October 9, 2026)
• IDFPR: Controlled substances registration instructions (IL486-2537, 3/24) (checked October 9, 2026)
• Illinois Prescription Monitoring Program: PMP statute requirements (checked October 9, 2026)
• Illinois Supreme Court, Berlin v. Sarah Bush Lincoln Health Center, 179 Ill. 2d 1 (October 23, 1997): opinion (Caselaw Access Project) (checked October 9, 2026)
• Insurance Claims Fraud Prevention Act, 740 ILCS 92/5: Illinois General Assembly (checked October 9, 2026)
• eCFR, 21 CFR 1308.13(c)(7): Ketamine in Schedule III (checked October 9, 2026)
• eCFR, 21 CFR 1301.12: Separate DEA registrations for separate locations (checked October 9, 2026)
• FDA: Spravato prescribing information, revised April 2025 (REMS and two-hour monitoring) (checked October 9, 2026)
• FDA: Ketalar prescribing information, revised March 2026 (indications) (checked October 9, 2026)
• 18 U.S.C. § 220, via Cornell LII: Illegal remunerations for referrals to recovery homes and clinical treatment facilities (checked October 9, 2026)